Molecular regulations governing TREK and TRAAK channel functions

Channels

Volumn 5, Issue 5, 2011, Pages

  Noël, Jacques ^a,b   Sandoz, Guillaume ^a,b,c   Lesage, Florian ^a,b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CNRS   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Molecular regulations; TREK TRAAK

Indexed keywords

G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; POTASSIUM CHANNEL; TWIK RELATED ARACHIDONIC ACID ACTIVATED POTASSIUM CHANNEL; TWIK RELATED POTASSIUM CHANNEL; TWIK RELATED POTASSIUM CHANNEL 1; TWIK RELATED POTASSIUM CHANNEL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ELECTRIC ACTIVITY; GENETIC HETEROGENEITY; GENETIC ORGANIZATION; HUMAN; INTRACELLULAR SIGNALING; MEMBRANE DEPOLARIZATION; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MUSCLE RELAXATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW;

EID: 80052626686     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.5.5.16469     Document Type: Review

References (100)

1. Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, et al. International Union of Pharmacology LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev 2005; 57:509-26.
2. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, et al. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 2005; 57:473-508.
3. Goldstein SA, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S. International Union of Pharmacology LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev 2005; 57:527-40.
4. + channel with a novel structure. EMBO J 1996; 15:1004-11.
5. + currents: two-pore domain potassium channels. Physiol Rev 2010; 90:559-605.
6. + channel. EMBO J 1996; 15:6854-62.
7. + channel subunits via a disulfide bridge. EMBO J 1996; 15:6400-7.
8. + channels with two pore domains. Kidney and Blood Pressure Research 2001; 24:402.
9. 2P potassium channels. J Am Chem Soc 2010; 132:8145-51.
10. 2P potassium channels based on 23 pairs of interacting sites and continuum electrostatics. J Gen Physiol 2009; 134:53-68.
11. Milac A, Anishkin A, Fatakia SN, Chow CC, Sukharev S, Guy HR. Structural models of TREK channels and their gating mechanism. Channels (Austin) 2011; 5:23-33.
12. Garry A, Fromy B, Blondeau N, Henrion D, Brau F, Gounon P, et al. Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link. EMBO Rep 2007; 8:354-9. (Pubitemid 46519748)
13. Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thummler S, Peng XD, et al. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 2006; 9:1134-41. (Pubitemid 44306306)
14. + channel involved in neuroprotection and general anesthesia. EMBO J 2004; 23:2684-95. (Pubitemid 38988239)
15. + channel involved in polymodal pain perception. EMBO J 2006; 25:2368-76.
16. + channels TRAAK and TREK-1 control both warm and cold perception. EMBO J 2009; 28:1308-18.
17. + channel family. J Biol Chem 2000; 275:17412-9. (Pubitemid 30430778)
18. q protein-coupled receptors. J Biol Chem 2000; 275:28398-405.
19. + channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J 1998; 17:3297-308.
20. Bockenhauer D, Zilberberg N, Goldstein SA. KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel. Nat Neurosci 2001; 4:486-91. (Pubitemid 32397185)
21. Xian Tao L, Dyachenko V, Zuzarte M, Putzke C, Preisig-Muller R, Isenberg G, Daut J. The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle. Cardiovasc Res 2006; 69:86-97. (Pubitemid 41814814)
22. Gu W, Schlichthorl G, Hirsch JR, Engels H, Karschin C, Karschin A, et al. Expression pattern and functional characteristics of two novel splice variants of the two-pore- domain potassium channel TREK-2. J Physiol 2002; 539:657-68. (Pubitemid 35175418)
23. Talley EM, Solorzano G, Lei Q, Kim D, Bayliss DA. Cns distribution of members of the two-pore-domain (KCNK) potassium channel family. J Neurosci 2001; 21:7491-505. (Pubitemid 32904948)
24. + channel. FEBS Lett 2000; 471:137-40.
25. + channel gene KCNK4. Chromosomal localization, tissue distribution and functional expression. Brain Res Mol Brain Res 2002; 102:18-27.
26. Veale EL, Rees KA, Mathie A, Trapp S. Dominant negative effects of a non-conducting TREK1 splice variant expressed in brain. J Biol Chem 2010; 285:29295-304.
27. + channel expression and trafficking. J Neurosci 2008; 28:8545-52.
28. 2P2.1 potassium channels permeable to sodium. Neuron 2008; 58:859-70.
29. 2P10.1 (TREK-2) by the amino-terminus: role of alternative translation initiation. J Physiol 2008; 586:5651-63.
30. Hervieu GJ, Cluderay JE, Gray CW, Green PJ, Ranson JL, Randall AD, Meadows HJ. Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS. Neuroscience 2001; 103:899-919. (Pubitemid 32289303)
31. Aller MI, Wisden W. Changes in expression of some two-pore domain potassium channel genes (KCNK) in selected brain regions of developing mice. Neuroscience 2008; 151:1154-72.
32. Medhurst AD, Rennie G, Chapman CG, Meadows H, Duckworth MD, Kelsell RE, et al. Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res Mol Brain Res 2001; 86:101-14.
33. Meadows HJ, Benham CD, Cairns W, Gloger I, Jennings C, Medhurst AD, et al. Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel. Pflugers Arch 2000; 439:714-22. (Pubitemid 30191145)
34. Han J, Truell J, Gnatenco C, Kim D. Characterization of four types of background potassium channels in rat cerebellar granule neurons. J Physiol 2002; 542:431-44. (Pubitemid 35190305)
35. + channel in cultured rat brain astrocytes. Brain Res 2002; 931:56-67.
36. Zhou M, Xu G, Xie M, Zhang X, Schools GP, Ma L, et al. TWIK-1 and TREK-1 are potassium channels contributing significantly to astrocyte passive conductance in rat hippocampal slices. J Neurosci 2009; 29:8551-64.
37. Descoeur J, Pereira V, Pizzoccaro A, Francois A, Ling B, Maffre V, et al. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol Med 2011; 3:266-78.
38. + channels in dorsal root ganglion neurons. Am J Physiol Cell Physiol 2006; 291:138-46.
39. + channels TREK-2 and TRAAK. J Physiol 2005; 564:103-16.
40. Zhao H, Sprunger LK, Simasko SM. Expression of transient receptor potential channels and two-pore potassium channels in subtypes of vagal afferent neurons in rat. Am J Physiol Gastrointest Liver Physiol 2010; 298:212-21.
41. Cadaveira-Mosquera A, Ribeiro SJ, Reboreda A, Perez M, Lamas JA. Activation of TREK currents by the neuroprotective agent riluzole in mouse sympathetic neurons. J Neurosci 2011; 31:1375-85.
42. Sanders KM, Koh SD. Two-pore-domain potassium channels in smooth muscles: new components of myogenic regulation. J Physiol 2006; 570:37-43.
43. + channels. Br J Pharmacol 2008; 153:1259-71.
44. Tichenor JN, Hansen ET, Buxton IL. Expression of stretch-activated potassium channels in human myometrium. Proc West Pharmacol Soc 2005; 48:44-8. (Pubitemid 43053798)
45. Buxton IL, Singer CA, Tichenor JN. Expression of stretch-activated two-pore potassium channels in human myometrium in pregnancy and labor. PLoS One 2010; 5:12372.
46. Blondeau N, Petrault O, Manta S, Giordanengo V, Gounon P, Bordet R, et al. Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res 2007; 101:176-84. (Pubitemid 47196585)
47. Gardener MJ, Johnson IT, Burnham MP, Edwards G, Heagerty AM, Weston AH. Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol 2004; 142:192-202. (Pubitemid 38698208)
48. Terrenoire C, Lauritzen I, Lesage F, Romey G, Lazdunski M. A TREK-1-like potassium channel in atrial cells inhibited by beta-adrenergic stimulation and activated by volatile anesthetics. Circ Res 2001; 89:336-42. (Pubitemid 34132672)
49. Gurney A, Manoury B. Two-pore potassium channels in the cardiovascular system. Eur Biophys J 2009; 38:305-18.
50. Kelly D, Mackenzie L, Hunter P, Smaill B, Saint DA. Gene expression of stretch-activated channels and mechanoelectric feedback in the heart. Clin Exp Pharmacol Physiol 2006; 33:642-8. (Pubitemid 43894028)
51. +-absorbing H441 human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2007; 292:1304-12.
52. + channel in adrenocortical cells is TREK-1. J Biol Chem 2002; 277:49186-99.
53. + channels couple angiotensin II receptors to membrane depolarization and aldosterone secretion in bovine adrenal glomerulosa cells. Am J Physiol Endocrinol Metab 2004; 287:1154-65.
54. Brenner T, O'Shaughnessy KM. Both TASK-3 and TREK-1 two-pore loop K channels are expressed in H295R cells and modulate their membrane potential and aldosterone secretion. Am J Physiol Endocrinol Metab 2008; 295:1480-6.
55. Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, et al. TREK-1 is a novel molecular target in prostate cancer. Cancer Res 2008; 68:1197-203. (Pubitemid 351272239)
56. Zhang H, Shepherd N, Creazzo TL. Temperature-sensitive TREK currents contribute to setting the resting membrane potential in embryonic atrial myocytes. J Physiol 2008; 586:3645-56.
57. Mongahan K, Baker SA, Dwyer L, Hatton WC, Park KS, Sanders KM, Koh SD. The Stretch-Dependent Potassium Conductance (TREK-1)and Its Function in Murine Myometrium. J Physiol 2011.
58. + channels. Nat Neurosci 1999; 2:422-6. (Pubitemid 30491251)
59. + channels are a novel target for the anesthetic gases xenon, nitrous oxide and cyclopropane. Mol Pharmacol 2004; 65:443-52. (Pubitemid 38134273)
60. Punke MA, Licher T, Pongs O, Friederich P. Inhibition of human TREK-1 channels by bupivacaine. Anesth Analg 2003; 96:1665-73. (Pubitemid 36623123)
61. + channel TREK1 by local anesthetic lidocaine: negative cooperativity and half-of-sites saturation kinetics. Mol Pharmacol 2009; 76:903-17.
62. + channels TREK-1 and TRAAK. Mol Pharmacol 2000; 57:906-12.
63. Kennard LE, Chumbley JR, Ranatunga KM, Armstrong SJ, Veale EL, Mathie A. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br J Pharmacol 2005; 144:821-9. (Pubitemid 40516121)
64. + channel. EMBO J 1998; 17:4283-90.
65. Thummler S, Duprat F, Lazdunski M. Antipsychotics inhibit TREK but not TRAAK channels. Biochem Biophys Res Commun 2007; 354:284-9. (Pubitemid 46137960)
66. Sandoz G, Bell SC, Isacoff EY. Optical probing of a dynamic membrane interaction that regulates the TREK1 channel. Proc Natl Acad Sci USA 2011; 108:2605-10.
67. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honore E. Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem 1999; 274:26691-6.
68. 2P channels. Proc Natl Acad Sci USA 2006; 103:6859-64.
69. + channel. J Biol Chem 1999; 274:1381-7.
70. + channels. Curr Opin Cell Biol 2001; 13:422-8.
71. + channel TREK-1. EMBO J 2002; 21:2968-76. (Pubitemid 34670381)
72. + channels by pressure, free fatty acids and alkali. Pflugers Arch 2001; 442:64-72.
73. + channel domains that regulate channel kinetics and sensitivity to pressure, fatty acids and pHi. Pflugers Arch 2001; 442:952-60. (Pubitemid 32900456)
74. + channel TREK-1. EMBO J 2005; 24:44-53.
75. + channel. EMBO J 2000; 19:2483-91.
76. + channel TASK-1. EMBO J 2001; 20:47-54.
77. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000; 19:1784-93. (Pubitemid 30204390)
78. + channels TREK-1 and TRAAK. J Biol Chem 2000; 275:10128-33.
79. Chemin J, Patel AJ, Duprat F, Sachs F, Lazdunski M, Honore E. Up and downregulation of the mechano-gated K(2P) channel TREK-1 by PIP (2) and other membrane phospholipids. Pflugers Arch 2007; 455:97-103. (Pubitemid 47403975)
80. + channels. J Physiol 2005; 564:117-29.
81. + channels. EMBO J 2003; 22:5403-11.
82. Murbartian J, Lei Q, Sando JJ, Bayliss DA. Sequential phosphorylation mediates receptor- and kinase-induced inhibition of TREK-1 background potassium channels. J Biol Chem 2005; 280:30175-84. (Pubitemid 41216196)
83. Sandoz G, Douguet D, Chatelain F, Lazdunski M, Lesage F. Extracellular acidification exerts opposite actions on TREK1 and TREK2 potassium channels via a single conserved histidine residue. Proc Natl Acad Sci USA 2009; 106:14628-33.
84. 2P2.1 channel gating. Facilitation of C-type gating by protonation of extracellular histidine residues. J Biol Chem 2008; 283:19448-55.
85. 2+- and ATP hydrolysis-dependent mechanisms. J Biol Chem 2005; 280:30814-28.
86. q-coupled M3 muscarinic receptor. Am J Physiol Cell Physiol 2006; 291:649-56.
87. Mathie A. Neuronal two-pore-domain potassium channels and their regulation by G protein-coupled receptors. J Physiol 2007; 578:377-85. (Pubitemid 46092203)
88. Cain SM, Meadows HJ, Dunlop J, Bushell TJ. mGlu4 potentiation of K(2P)2.1 is dependant on C-terminal dephosphorylation. Mol Cell Neurosci 2008; 37:32-9. (Pubitemid 350299992)
89. + channels. Neuron 2009; 63:230-43.
90. + channels. J Biol Chem 2009; 284:10980-91.
91. 2P channel TREK-1 and the actin cytoskeleton. EMBO Rep 2005; 6:642-8.
92. Sandoz G, Lesage F. Protein complex analysis of native brain potassium channels by proteomics. Methods Mol Biol 2008; 491:113-23.
93. + channels into open leak channels. EMBO J 2006; 25:5864-72.
94. Welch EJ, Jones BW, Scott JD. Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 2010; 10:86-97.
95. Kim E, Hwang EM, Yarishkin O, Yoo JC, Kim D, Park N, et al. Enhancement of TREK1 channel surface expression by protein-protein interaction with beta-COP. Biochem Biophys Res Commun 2010; 395:244-50.
96. + channels TASK-1 and TASK-3: role of N- and C-terminal sorting signals and interaction with 14-3-3 proteins. J Physiol 2009; 587:929-52.
97. O'Kelly I, Butler MH, Zilberberg N, Goldstein SA. Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell 2002; 111:577-88.
98. Mathie A, Rees KA, El Hachmane MF, Veale EL. Trafficking of neuronal two pore domain potassium channels. Curr Neuropharmacol 2010; 8:276-86.
99. Mazella J, Petrault O, Lucas G, Deval E, Beraud- Dufour S, Gandin C, et al. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol 2010; 8:1000355.
100. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004; 427:843-8. (Pubitemid 38297746)